droxidopa has been researched along with AL Amyloidosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, AH; Kinter, CW; Krakow, D; Neelam, AR; Wight, J | 1 |
1 other study(ies) available for droxidopa and AL Amyloidosis
| Article | Year |
|---|---|
Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
Topics: Antiparkinson Agents; Bradycardia; Droxidopa; Humans; Hypotension, Orthostatic; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged | 2020 |